Monday, October 7, 2002 - Including Plenary Sessions

ASTRO 2002

ASTRO 02Catherine DeAngelis, MD, Editor of JAMA presents Keynote Address at this year's ASTRO meeting.



Biochemical Outcomes Following Prostate Brachytherapy with 5-year Minimum Follow-up: The Importance of Patient Selection and Implant Quality
Brachytherapy Versus Brachytherapy Plus Beam Radiation for Prostate Cancer: Morbidity Outcomes from Two Prospective Randomized Multicenter Trials
Conflicts of Interest In Science
Eighteen-Year Results in the Treatment of Early-Stage Breast Cancer With Breast Conservation Versus Mastectomy
Is Previous Transurethral Resection of the Prostate a Contraindication to Brachytherapy
Larynx Preservation and Tumor Control in Stage III and IV Laryngeal Cancer: A Three-Arm Randomized Intergroup Trial; RTOG 91?11
Long-Term Outcome by Risk Factors Using Conformal High Dose Rate Boost for Prostate Cancer
Pathologic Evidence of Dose-Response and Dose-Volume Relationships for Prostate Cancer Treated with Combined External Beam Radiotherapy and High-Dose-Rate Brachytherapy
Patterns of Failure for Resected Advanced Head & Neck Cancer Treated by Concurrent Chemotherapy and Radiation Therapy: An Analysis of RTOG 9501/Intergroup Phase III Trial
Pelvic Radiation With Concurrent Chemotherapy versus Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer: An Update of RTOG 90-01
Radiation Therapy With or Without Chemotherapy for Cervical Cancer With Periaortic Lymph Node Metastases
Randomized Study Comparing Adjuvant Radiotherapy (RT) with Concomitant Chemotherapy (CT) Versus Sequential Treatment After Conservative Surgery for Patients with Stages I and II Breast Carcinoma
Screening Mammography Is Associated with Earlier Stage Disease and Greater Eligibility for Breast Conservation in Women Aged 40 and Older with Breast Cancer
Significant Relationship Between Hemoglobin (Hb) Levels and Quality of Life (QOL) During Chemoradiation: Findings From an Incremental Analysis of a 442-Patient, Prospective, Community-Based Epoetin Alfa Study
Stereotactic Radiosurgery with Whole Brain Radiation Therapy Improves Survival in Patients with Brain Metastases: Report of Radiation Therapy Oncology Group Phase III Study 95-08